14:49

TMA Symposium - Closing Remarks on aHUS Advocacy

09:28

Panel Discussion - TMA Symposium

41:49

TMA & aHUS: What to Treat & How to Treat It

55:18

Pregnancy and aHUS

05:35

Tribute - TMA Symposium in Boston 24 Aug 2017

42:14

Family Genetics and a C3 Variant

53:33

aHUS as a TMA: A Hematologist's Perspective

47:18

TMA Multidisciplinary Team Approach: Accelerating the Pathway to Diagnosis

24:48

Welcome & Opening Remarks - TMA Symposium, 24 Aug 2017

02:58

ahusfacts

42:03

Transplantation for Atypical HUS: Before and After

36:00

The Complement System Made Simple

36:44

aHUS Diagnosis, Treatment and New Horizons

12:34

Current Research on aHUS

16:11

Genetic Testing Process

15:39

Rare Disease Challenges Support for Patients & Families

49:38

RareConnect's atypical HUS community webinar with Dr Tim Goodship

05:58

MORL Genetic Screening Process

01:34

aHUS Information –Discovery Timeline

02:54

Diagnosis of aHUS

01:13

Alternative Pathway Features and Factors

01:27

aHUS Symptoms –Concerns and Associated Complications

01:29

aHUS Statistics– Now and Then

00:55

The Complement Cascade

01:19

Importance of Genetic Testing

07:00

Cascade Variants

03:03

Kidney-Liver Transplants

01:22

Physician Considerations for aHUS Transplant Candidates

01:47

Challenges with Plasma Therapy

02:46

Considerations for Plasma Treatment Plans

04:01

When Should Plasmatherapy be Considered

00:55

Anti-Complement Therapeutics

01:50

Plasmatherapy for Acute and Long-Term Treatment

01:34

Plasmapheresis and Factors H and I

00:57

Complement Activation in aHUS

02:53

aHUS and Eculizumab - Data from Studies

01:20

Eculizumab in 2009 Transplant Case (Factor H)

02:01

Considerations with Eculizumab

01:06

Eculizumab and the Complement Cascade

00:56

Eculizumab Cost vs Expenses of Other aHUS Treatments

01:27

Eculizumab - Resemblance to a Human Protein

02:11

Kidney Transplants with Eculizumab

02:33

Eculizumab, Transplants, and Antibody Reactions

01:06

Kidney Transplant - Eculizumab Protocol

03:34

Eculizumab and its Use with Kidney Disease

02:37

Eculizumab and Future Drugs

01:22

Complement Control and aHUS MAC Attack

03:29

The Complement Cascade

05:58

MORL- Genetic Screening Process

01:10

Genetic Testing Future Platforms

02:21

Recombinant Factor H - Future Treatment-

02:46

Complement Factor H (SCRs)

01:53

aHUS Mutations - Variants in Factor I, Factor H, and MPC

03:01

Laboratory Tests to Monitor aHUS

04:49

Options for aHUS Patients with Kidney Failure ESRD

02:02

Suspecting a Diagnosis of aHUS

02:16

Genetic Screening and aHUS

01:15

Findings Confirmed in Other Labs

03:57

A Platform for Novel aHUS Gene Discovery

00:53

Phenotype Components